Insys Therapeutics

SUNY officially revokes Kapoor name from UB's Pharmacy School

By • Jun 20, 2019
University at Buffalo

The State University of New York Board of Trustees on Thursday revoked the names of John and Editha Kapoor from the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences. The school is now officially named the Pharmacy Building.

Insys Files For Chapter 11, Days After Landmark Opioid Settlement Of $225 Million

By • Jun 11, 2019

Opioid manufacturer Insys Therapeutics has filed for Chapter 11 bankruptcy protection, just five days after agreeing to pay $225 million to settle the federal government's criminal and civil cases against the company for bribing doctors to prescribe its fentanyl-based painkiller.

Opioid-Maker Insys Admits To Bribing Doctors, Agrees To Pay $225 Million Settlement

By • Jun 6, 2019

Insys Therapeutics, an opioid manufacturer, has agreed to pay $225 million to settle the federal government's criminal and civil investigations into the company's marketing practices. As part of the settlement, Insys Therapeutics admitted to bribing doctors to prescribe its opioid painkiller.

Last month, a federal jury in Boston found five top Insys Therapeutics executives guilty of racketeering conspiracy for these same practices. Now, the federal government is holding the company accountable.

UB revokes Kapoor's name from pharmacy school

By & • Jun 3, 2019
Steven Senne / AP

The University at Buffalo Council has passed a resolution to “un-name” the pharmacy school building named in honor of John Kapoor. Kapoor was convicted of racketeering conspiracy by a federal jury last month.

Opioid Executive John Kapoor Found Guilty In Landmark Bribery Case

By • May 2, 2019

Updated 5:30 p.m. ET

A jury in Boston has found onetime billionaire and drug company executive John Kapoor and his four co-defendants guilty of a racketeering conspiracy. The verdict came Wednesday after 15 days of deliberation.